Advancing Care Through Research and Clinical Trials
At UConn Health’s Neag Comprehensive Cancer Center, we’re advancing cancer care through research. From basic scientific discoveries at the bench to clinical trials at the bedside, we are changing how cancer is understood and creating new treatment options for our patients. Learn more about the groundbreaking work we’re doing and help us shape the future of medicine.
Questions About Clinical Trials
Clinical research studies (also known as clinical trials) use volunteer participants to evaluate health risks and test new ways to diagnose, treat, and prevent cancer.
Clinical Trials and Novel Therapies
The Clinical Trials Office (CTO) within the Carole and Ray Neag Comprehensive Cancer Center supports high-quality, patient-focused cancer research. The CTO allows UConn Health to offer innovative treatment options for patients and novel research and education opportunities for academic faculty, trainees, and students.
The CTO was created to provide a dedicated team to support UConn Health practitioners in the develop and conduct of clinical trials research in oncology. By supporting clinical research, the CTO aids UConn Health meet its goals of excellence in patient care, education, and research. The CTO collaborates with academic, philanthropic, and community and pharmaceutical partners to bring cancer research studies to UConn Health.
Current Membership Status
- CTSU (Cancer Trials Support Unit)
- ACCRU (The Academic and Community Cancer Research United)
Areas of Cancer Expertise
Clinical Trials & Novel Therapies
UConn Health was the first in the US to administer a new drug approved by the FDA to treat patients with multiple myeloma who have exhausted other treatment options.
Clinical Trials & Novel Therapies
Colonoscopy Just the Start in Preventing Colorectal Cancer
Research at UConn Health has uncovered predictors of the development of polyps that can lead to colorectal cancer.
Prevention & Screening
Center for Molecular Oncology
The Center for Molecular Biology aims to provide a fertile environment and forum for basic and clinical/translational investigators interested in molecular and genetic approaches to better understand and potentially prevent/treat human neoplasia.
Center for Molecular Oncology
Immunology and Immunotherapy
We're using innovative approaches and novel tools to aid vaccine and immunotherapy development and formulate new methods to diagnose and treat autoimmune diseases.
Department of Immunology
Vascular Biology Program
Research in the Shapiro Laboratory is focused on understanding the physiological and pathological regulation and function of two M1 family cell surface peptidases CD13/aminopeptidase N and PSMA/glutamate carboxy-peptidase II.
Center for Vascular BiologyBone Neoplasia Program
Sickle Cell Program
Experimental Drug Giving New Hope to Sickle Cell Patients Around the World
New England Sickle Cell Institute
UConn Biorepository
The UConn Health Research Biorepository consists of de-identified tissue and/or blood samples and patient data obtained from consented patients coupled with a database of clinical and laboratory data.
Research Tissue Biorepository Core FacilityNeag Comprehensive Cancer Center
In the News
From breakthrough research studies to innovative clinical trials, the Cancer Center’s expertise is regularly featured in local and national news stories.
